CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
CDK4/6-Cyclin D pathway is often deregulated in cancer; therefore specific inhibitors have been developed. Here the authors show that treatment with CDK4/6 inhibitors activate autophagy in breast cancer cells; thus, combination of such inhibitors with autophagy inhibitors results in a synergistic ef...
Guardado en:
Autores principales: | Smruthi Vijayaraghavan, Cansu Karakas, Iman Doostan, Xian Chen, Tuyen Bui, Min Yi, Akshara S. Raghavendra, Yang Zhao, Sami I. Bashour, Nuhad K. Ibrahim, Meghan Karuturi, Jing Wang, Jeffrey D. Winkler, Ravi K. Amaravadi, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29244e97db3b4325b02bb495622f99c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
por: Ang Gao, et al.
Publicado: (2018) -
Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability
por: Rafaela Fagundes, et al.
Publicado: (2021) -
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
por: Grzegorz Sarek, et al.
Publicado: (2010) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
por: Lindsey R. Pack, et al.
Publicado: (2021) -
AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy
por: Marc Dohmen, et al.
Publicado: (2020)